High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients
…, N de-la-Torre-Ferrera, JC Barraza-Vengoechea… - Journal of …, 2020 - Elsevier
Objective Severely ill COVID-19 patients may end in acute respiratory distress syndrome (ARDS)
and multi-organ failure. Some of them develop a systemic hyperinflammatory state …
and multi-organ failure. Some of them develop a systemic hyperinflammatory state …
[HTML][HTML] Corticosteroid pulses for hospitalized patients with COVID-19: effects on mortality
…, M Lopez-Veloso, J Barraza-Vengoechea… - Mediators of …, 2021 - ncbi.nlm.nih.gov
Objectives To assess the influence of corticosteroid pulses on 60-day mortality in hospitalized
patients with severe COVID-19. Methods We designed a multicenter retrospective cohort …
patients with severe COVID-19. Methods We designed a multicenter retrospective cohort …
[PDF][PDF] Research Article Corticosteroid Pulses for Hospitalized Patients with COVID-19: Effects on Mortality
…, M Lopez-Veloso, J Barraza-Vengoechea… - 2021 - scienceopen.com
Objectives. To assess the influence of corticosteroid pulses on 60-day mortality in hospitalized
patients with severe COVID-19. Methods. We designed a multicenter retrospective cohort …
patients with severe COVID-19. Methods. We designed a multicenter retrospective cohort …
Corticosteroid pulses for hospitalized patients with COVID-19. Effects on mortality and in-hospital stay.
…, M Lopez-Veloso, J Barraza-Vengoechea… - 2020 - pesquisa.bvsalud.org
Background: COVID-19 has high mortality in hospitalized patients, and we need effective
treatments. Our objective was to assess corticosteroid pulses influence on 60-days mortality in …
treatments. Our objective was to assess corticosteroid pulses influence on 60-days mortality in …
[HTML][HTML] Efficacy and safety of sarilumab in patients with COVID19 pneumonia: a randomized, phase III clinical trial (SARTRE study)
A Sancho-López, AF Caballero-Bermejo… - Infectious diseases and …, 2021 - Springer
Introduction SARS-CoV-2 pneumonia is often associated with hyper-inflammation. The
cytokine-storm-like is one of the targets of current therapies for coronavirus disease 2019 (COVID-…
cytokine-storm-like is one of the targets of current therapies for coronavirus disease 2019 (COVID-…
[HTML][HTML] Benefits of early aggressive immunomodulatory therapy (tocilizumab and methylprednisolone) in COVID-19: Single center cohort study of 685 patients
BM Luis, MB Miguel, DL Pedro, IP David, A Itziar… - Journal of translational …, 2021 - Elsevier
Introduction A growing evidence suggests that immune dysregulation and thrombotic
phenomena are key features in the pathophysiology of COVID-19. Apart from antivirals and …
phenomena are key features in the pathophysiology of COVID-19. Apart from antivirals and …
Benefits of early aggressive immunomodulatory therapy (tocilizumab and methylprednisolone) in COVID-19: Single center cohort study of 685 patients
MI Astigarraga Aguirre - 2021 - addi.ehu.es
Introduction: A growing evidence suggests that immune dysregulation and thrombotic
phenomena are key features in the pathophysiology of COVID-19. Apart from antivirals and …
phenomena are key features in the pathophysiology of COVID-19. Apart from antivirals and …
[PDF][PDF] Corticosteroids in covid-19: Optimizing observational research through target trial emulations
Background Observational research provides a unique opportunity to learn causal effects
when randomized trials are unavailable, but obtaining the correct estimates hinges on a …
when randomized trials are unavailable, but obtaining the correct estimates hinges on a …
[HTML][HTML] Uso de antirreumáticos en covid-19 desde la hidroxicloroquina hasta la anakinra pasando por tocilizumab y baricitinib: Una revisión de la literatura
RA Salas-Bolaños, DE Sevilla-Rodríguez… - Revista del Cuerpo …, 2021 - scielo.org.pe
Actualmente nos encontramos en una pandemia mundial causada por el coronavirus 2019
o COVID-19, presentando diferentes desafíos para el sistema de salud debido a que no se …
o COVID-19, presentando diferentes desafíos para el sistema de salud debido a que no se …
[PDF][PDF] Uso de antirreumáticos en covid-19 desde la hidroxicloroquina hasta la anakinra pasando por tocilizumab y baricitinib: Una revisión de la literatura
A AGUINAGAASENJO - Revista del Cuerpo Médico del HNAAA, 2021 - academia.edu
Actualmente nos encontramos en una pandemia mundial causada por el coronavirus 2019
o COVID–19, presentando diferentes desafíos para el sistema de salud debido a que no se …
o COVID–19, presentando diferentes desafíos para el sistema de salud debido a que no se …
